Clinical trial
A 3-Part, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose, and Proof of Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
NCT02377362 is registered in ClinicalTrials.gov with GLWL Research Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 3-Part, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose, and Proof of Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
- Lead sponsor
- GLWL Research Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 31, 2015
- Completion date
- November 9, 2016
- Enrollment
- 74 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.